These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 34059460)
1. Pharmacokinetics of a high-concentration formulation of buprenorphine (Simbadol) in male dogs. Hansford J; Henao-Guerrero N; Machado ML; Pypendop BH Vet Anaesth Analg; 2021 Jul; 48(4):509-516. PubMed ID: 34059460 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and analgesic effects of intravenous, intramuscular or subcutaneous buprenorphine in dogs undergoing ovariohysterectomy: a randomized, prospective, masked, clinical trial. Steagall PV; Ruel HLM; Yasuda T; Monteiro BP; Watanabe R; Evangelista MC; Beaudry F BMC Vet Res; 2020 May; 16(1):154. PubMed ID: 32448336 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic and pharmacodynamic modelling after subcutaneous, intravenous and buccal administration of a high-concentration formulation of buprenorphine in conscious cats. Doodnaught GM; Monteiro BP; Benito J; Edge D; Beaudry F; Pelligand L; Steagall P PLoS One; 2017; 12(4):e0176443. PubMed ID: 28445495 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and pharmacodynamics of a high concentration of buprenorphine (Simbadol) in conscious horses after subcutaneous administration. Flynn H; Cenani A; Brosnan RJ; DiMaio Knych HK; de Araujo Aguiar AJ Vet Anaesth Analg; 2021 Jul; 48(4):585-595. PubMed ID: 33934992 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of buprenorphine hydrochloride following intramuscular and intravenous administration to American kestrels (Falco sparverius). Gustavsen KA; Guzman DS; Knych HK; Petritz OA; Olsen GH; Paul-Murphy JR Am J Vet Res; 2014 Aug; 75(8):711-5. PubMed ID: 25061701 [TBL] [Abstract][Full Text] [Related]
6. Intravenous and sublingual buprenorphine in horses: pharmacokinetics and influence of sampling site. Messenger KM; Davis JL; LaFevers DH; Barlow BM; Posner LP Vet Anaesth Analg; 2011 Jul; 38(4):374-84. PubMed ID: 21501371 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic and pharmacodynamic modelling of intravenous, intramuscular and subcutaneous buprenorphine in conscious cats. Steagall PV; Pelligand L; Giordano T; Auberger C; Sear JW; Luna SP; Taylor PM Vet Anaesth Analg; 2013 Jan; 40(1):83-95. PubMed ID: 22998333 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of buprenorphine and its metabolite norbuprenorphine in neutered male cats anesthetized with isoflurane. Pypendop BH; Stoddard S; Barter LS Vet Anaesth Analg; 2023 Jul; 50(4):349-355. PubMed ID: 37270407 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of intravenous, oral transmucosal, and intranasal buprenorphine in healthy male dogs. Enomoto H; Love L; Madsen M; Wallace A; Messenger KM J Vet Pharmacol Ther; 2022 Jul; 45(4):358-365. PubMed ID: 35445748 [TBL] [Abstract][Full Text] [Related]
10. Human pharmacokinetics of intravenous, sublingual, and buccal buprenorphine. Kuhlman JJ; Lalani S; Magluilo J; Levine B; Darwin WD J Anal Toxicol; 1996 Oct; 20(6):369-78. PubMed ID: 8889672 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of buprenorphine following constant rate infusion for postoperative analgesia in dogs undergoing ovariectomy. Barbarossa A; Rambaldi J; Giunti M; Zaghini A; Cunto M; Zambelli D; Valgimigli S; Santoro F; Romagnoli N Vet Anaesth Analg; 2017 May; 44(3):435-443. PubMed ID: 28416162 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of buprenorphine following intravenous administration in dogs. Krotscheck U; Boothe DM; Little AA Am J Vet Res; 2008 Jun; 69(6):722-7. PubMed ID: 18518651 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of a Sustained Release Formulation of Buprenorphine After Intramuscular and Subcutaneous Administration to American Kestrels ( Falco sparverius ). Guzman DS; Knych HK; Olsen GH; Paul-Murphy JR J Avian Med Surg; 2017 Jun; 31(2):102-107. PubMed ID: 28644085 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of buprenorphine following intravenous and oral transmucosal administration in dogs. Abbo LA; Ko JC; Maxwell LK; Galinsky RE; Moody DE; Johnson BM; Fang WB Vet Ther; 2008; 9(2):83-93. PubMed ID: 18597246 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of buprenorphine following intravenous and buccal administration in cats, and effects on thermal threshold. Hedges AR; Pypendop BH; Shilo-Benjamini Y; Stanley SD; Ilkiw JE J Vet Pharmacol Ther; 2014 Jun; 37(3):252-9. PubMed ID: 24862514 [TBL] [Abstract][Full Text] [Related]
16. The pharmacokinetics and analgesic effects of extended-release buprenorphine administered subcutaneously in healthy dogs. Barletta M; Ostenkamp SM; Taylor AC; Quandt J; Lascelles BDX; Messenger KM J Vet Pharmacol Ther; 2018 Aug; 41(4):502-512. PubMed ID: 29521421 [TBL] [Abstract][Full Text] [Related]
17. The Pharmacokinetics and Local Tolerability of a Novel Sublingual Formulation of Buprenorphine. Lim SCB; Schug S; Krishnarajah J Pain Med; 2019 Jan; 20(1):143-152. PubMed ID: 29309700 [TBL] [Abstract][Full Text] [Related]